Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23204551.
- Also identified by DOI 10.1093/rheumatology/kes304.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.
Medical subject headings
- Arthritis, Rheumatoid
- Gene Silencing
- Group IV Phospholipases A2
- Macrophages
- Molecular Targeted Therapy
- Monocytes
- RNA, Small Interfering